ALT - Altimmune, Inc. Annual Revenue Growth (Last Twelve Months)

Brandmark of Altimmune, Inc. (ALT)

This TTM annual revenue growth chart illustrates the dynamics of Altimmune, Inc. (ALT), which utilizes peptide developments for the therapy of obesity and liver pathologies. The value of 30.00 determines the current status of the parameter. The drug Pemvidutide will provide significant pricing power by preserving muscle mass during weight loss. The company is currently undergoing a stage of costly testing, which temporarily increases research expenses.

Sales Growth YoY (Last Twelve Months): Altimmune Corp (ALT) for 02/11/2024 - 11/17/2026

Summary analytical data breakdowns for Altimmune (ALT)

- stock price and consensus target price:
Fundamental company valuation:Altimmune Corp ALT
Original product of altimmune.com

Adherence to strict ESG standards and the environmental optimization of Altimmune, Inc. (ALT) laboratories create a foundation for sustainable business scaling. The comparative year-over-year sales dynamics over a rolling period measure the percentage change in revenue for the last 12 months, allowing investors to conduct a real-time assessment of the company's sales expansion rates and operational resilience to macroeconomic pressure.

Who Altimmune, Inc. competes with

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) MBX|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)